BNP Paribas Arbitrage SA raised its position in Invacare Corporation (NYSE:IVC) by 40.8% during the third quarter, according to its most recent filing with the SEC. The firm owned 20,619 shares of the health services provider’s stock after purchasing an additional 5,973 shares during the period. BNP Paribas Arbitrage SA owned 0.06% of Invacare worth $325,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Invacare by 3.8% in the 2nd quarter. Vanguard Group Inc. now owns 2,934,593 shares of the health services provider’s stock worth $38,736,000 after purchasing an additional 107,359 shares during the period. Royce & Associates LP lifted its position in shares of Invacare by 11.8% in the 2nd quarter. Royce & Associates LP now owns 1,354,739 shares of the health services provider’s stock worth $17,883,000 after purchasing an additional 143,027 shares during the period. Northpointe Capital LLC lifted its position in shares of Invacare by 96.8% in the 3rd quarter. Northpointe Capital LLC now owns 1,151,700 shares of the health services provider’s stock worth $18,139,000 after purchasing an additional 566,574 shares during the period. State Street Corp lifted its position in shares of Invacare by 8.3% in the 2nd quarter. State Street Corp now owns 837,448 shares of the health services provider’s stock worth $11,054,000 after purchasing an additional 63,917 shares during the period. Finally, Elk Creek Partners LLC acquired a new position in shares of Invacare in the 2nd quarter worth approximately $9,760,000. Hedge funds and other institutional investors own 94.65% of the company’s stock.
Invacare Corporation (NYSE:IVC) traded down $0.15 during trading on Tuesday, hitting $17.00. 329,100 shares of the company were exchanged, compared to its average volume of 491,799. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.57 and a current ratio of 2.28. Invacare Corporation has a 52 week low of $9.90 and a 52 week high of $17.95.
Invacare (NYSE:IVC) last released its earnings results on Tuesday, November 7th. The health services provider reported ($0.41) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.43) by $0.02. Invacare had a negative net margin of 7.95% and a negative return on equity of 13.33%. The company had revenue of $250.91 million for the quarter, compared to the consensus estimate of $239.88 million. During the same quarter in the previous year, the company earned ($0.37) EPS. Invacare’s quarterly revenue was down 6.4% compared to the same quarter last year. equities research analysts expect that Invacare Corporation will post -2 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Thursday, January 4th will be given a dividend of $0.0125 per share. The ex-dividend date of this dividend is Wednesday, January 3rd. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.29%. Invacare’s payout ratio is presently -2.13%.
In related news, SVP Dean J. Childers sold 6,249 shares of the business’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $15.15, for a total transaction of $94,672.35. Following the transaction, the senior vice president now owns 44,875 shares in the company, valued at approximately $679,856.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.20% of the stock is owned by insiders.
A number of brokerages have recently issued reports on IVC. KeyCorp restated a “buy” rating and issued a $18.00 price target on shares of Invacare in a research report on Friday, November 10th. Zacks Investment Research downgraded shares of Invacare from a “hold” rating to a “sell” rating in a research report on Tuesday, November 14th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $15.00.
COPYRIGHT VIOLATION WARNING: “Invacare Corporation (IVC) Stake Lifted by BNP Paribas Arbitrage SA” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2017/12/12/invacare-corporation-ivc-stake-lifted-by-bnp-paribas-arbitrage-sa.html.
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.
Want to see what other hedge funds are holding IVC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invacare Corporation (NYSE:IVC).
Receive News & Ratings for Invacare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.